US Stem Cell Inc
OTC:USRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
US Stem Cell Inc
OTC:USRM
|
US |
|
Bravura Solutions Ltd
ASX:BVS
|
AU |
|
Edreams Odigeo SA
OTC:EDEMY
|
ES |
|
Bitcoin Group SE
XETRA:ADE
|
DE |
|
T
|
T'way Air Co Ltd
KRX:091810
|
KR |
|
H
|
Heritage Distilling Holding Company Inc
NASDAQ:IPST
|
US |
|
Aker Carbon Capture ASA
OSE:ACC
|
NO |
|
C
|
Crescita Therapeutics Inc
OTC:CRRTF
|
CA |
|
China Hi-Tech Group Co Ltd
SSE:600730
|
CN |
|
F
|
Fielmann Group AG
XMUN:FIE
|
DE |
|
Datatec Ltd
F:DTT0
|
ZA |
|
India Tourism Development Corp Ltd
NSE:ITDC
|
IN |
|
B
|
Blue Innovation Co Ltd
TSE:5597
|
JP |
|
Shandong Publishing & Media Co Ltd
SSE:601019
|
CN |
Bankruptcy Probability
US Stem Cell Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
US Stem Cell Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
US Stem Cell Inc
OTC:USRM
|
63.4k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
60.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
US Stem Cell Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, US Stem Cell Inc has total debt of 5m USD. This includes both short-term (4.3m USD) and long-term (682k USD) debt.
You can find a full breakdown on its Balance Sheet.
